Developmental trajectory of intestinal MDR1/ABCB1 mRNA expression in children

British Journal of Clinical Pharmacology

Volumn 77, Issue 5, 2014, Pages 910-912

  Mizuno, Tomoyuki ^a,b   Fukuda, Tsuyoshi ^a,c   Masuda, Satohiro ^b   Uemoto, Shinji ^b   Matsubara, Kazuo ^b   Inui, Ken Ichi ^b,d   Vinks, Alexander A ^a,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN;

ADOLESCENT; ADULT; CHILD; CHILD DEVELOPMENT; FEMALE; HUMAN; HUMAN TISSUE; INFANT; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE; GENETICS; INTESTINE; METABOLISM; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTESTINES; MALE; P-GLYCOPROTEINS; RNA, MESSENGER;

EID: 84899066256     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12211     Document Type: Letter

References (10)

1. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE,. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349: 1157-1167.
2. Mooij MG, de Koning BA, Huijsman ML, de Wildt SN,. Ontogeny of oral drug absorption processes in children. Expert Opin Drug Metab Toxicol 2012; 8: 1293-1303.
3. Johnson TN, Tanner MS, Taylor CJ, Tucker GT,. Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis. Br J Clin Pharmacol 2001; 51: 451-460.
4. Lin JH, Yamazaki M,. Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 2003; 42: 59-98.
5. Masuda S, Goto M, Fukatsu S, Uesugi M, Ogura Y, Oike F, Kiuchi T, Takada Y, Tanaka K, Inui K,. Intestinal MDR1/ABCB1 level at surgery as a risk factor of acute cellular rejection in living-donor liver transplant patients. Clin Pharmacol Ther 2006; 79: 90-102.
6. Mooij MG, de Wildt SN, de Koning BA, Schwarz UI, Samson JN, Spaans E, Tibboel D, Kim RB,. Developmental change in human intestinal and hepatic drug transporter expression. 2013: [Late breaking abstract for the 114th American Society for Clinical Pharmacology and Therapeutics Annual Meeting].
7. van Kalken CK, Giaccone G, van der Valk P, Kuiper CM, Hadisaputro MM, Bosma SA, Scheper RJ, Meijer CJ, Pinedo HM,. Multidrug resistance gene (P-glycoprotein) expression in the human fetus. Am J Pathol 1992; 141: 1063-1072.
8. Guner YS, Franklin AL, Chokshi NK, Castle SL, Pontarelli E, Wang J, Wang L, Prasadarao NV, Upperman JS, Grishin AV, Ford HR,. P-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis. Lab Invest 2011; 91: 1668-1679.
9. Mooij MG, de Wildt SN, de Koning BA, Schwarz UI, Tibboel D, Kim RB,. Lower MDR1 mRNA expression in hepatic fetal and pediatric tissue compared to adults. Clin Pharmacol Ther 2013; 93: S63. [Abstract for the 114th American Society for Clinical Pharmacology and Therapeutics Annual Meeting].
10. Klaassen CD, Aleksunes LM,. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 2010; 62: 1-96.